Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Email alerts
Commentary/Editorials
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
Stefani
Spranger
,
Thomas F.
Gajewski
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
43;
DOI:
10.1186/s40425-015-0089-6
Introducing the clinical trials monitor: a new section of the journal for immunotherapy of cancer
Leisha A.
Emens
,
Pedro
Romero
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
49;
DOI:
10.1186/s40425-015-0092-y
The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
Thaïs
Baert
,
Tina
Verschuere
,
Anaïs
Van Hoylandt
,
Rik
Gijsbers
,
Ignace
Vergote
,
An
Coosemans
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
57;
DOI:
10.1186/s40425-015-0102-0
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
Lisa H
Butterfield
,
Mary L
Disis
,
Bernard A
Fox
,
Samir N
Khleif
,
Francesco M
Marincola
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
8;
DOI:
10.1186/s40425-015-0052-6
Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfolds
Michael
Kalos
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
5;
DOI:
10.1186/s40425-016-0108-2
A role for pre-mNK cells in tumor progression
Carolyn
Rosinsky
,
Paul Andrew
Antony
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
16;
DOI:
10.1186/s40425-016-0120-6
Natural killer cell immunotherapy to target stem-like tumor cells
Steven K.
Grossenbacher
,
Robert J.
Canter
,
William J.
Murphy
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
19;
DOI:
10.1186/s40425-016-0124-2
Targetless T cells in cancer immunotherapy
Per
thor Straten
,
Federico
Garrido
Journal for ImmunoTherapy of Cancer
Dec 2016,
4
(1)
23;
DOI:
10.1186/s40425-016-0127-z
Viruses, bacteria, and parasites – oh my! a resurgence of interest in microbial-based therapy for cancer
Andrew
Zloza
Journal for ImmunoTherapy of Cancer
Dec 2018,
6
(1)
3;
DOI:
10.1186/s40425-017-0312-8
Immune checkpoint inhibitor-related acral vasculitis
Thibault
Comont
,
Vincent
Sibaud
,
Loïc
Mourey
,
Pierre
Cougoul
,
Odile
Beyne-Rauzy
Journal for ImmunoTherapy of Cancer
Dec 2018,
6
(1)
120;
DOI:
10.1186/s40425-018-0443-6
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »
Special collections
COVID-19
(46)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(587)
Cancer Immunotherapy in Understudied Populations
(4)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(1020)
Commentary/Editorials
(159)
Computational I-O
(5)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(57)
Guidelines and Consensus Statements
(48)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(260)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(459)
Liquid Biopsies
(8)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(157)
Reviews
(250)
SITC 40th Anniversary: I-O Progress and Potential
(1)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(6586)
Press releases
(4)
